Stefan Prechtl
14Patents
2h-index
38Co-inventors
46Inventor score
Filing activity: Apr 24, 2010 → Mar 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9340528B2 | Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US9643953B2 | Substituted benzylpyrazoles | Chemistry; Metallurgy | 4 | Active |
| US10266548B2 | Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases | Chemistry; Metallurgy | 1 | Active |
| US8551980B2 | Substituted triazolopyridines | Human Necessities | 1 | Active |
| US9555022B2 | Substituted triazolopyridines | Chemistry; Metallurgy | 0 | Active |
| US8729082B2 | Substituted imidazoquinoxalines | Human Necessities | 0 | Active |
| US9676766B2 | Triazolopyridines | Human Necessities | 0 | Active |
| US9468642B2 | Imidazopyrazines | Chemistry; Metallurgy | 0 | Active |
| US9265763B2 | Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases | General | 0 | Revoked |
| US10604532B2 | Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases | Chemistry; Metallurgy | 0 | Active |
| US9422268B2 | Substituted benzylpyrazoles | General | 0 | Revoked |
| US9260412B2 | Substituted benzylpyrazoles | General | 0 | Revoked |
| US9416125B2 | Substituted cycloalkenopyrazoles as BUB1 inhibitors for the treatment of cancer | General | 0 | Revoked |
| US9682995B2 | Amino-substituted isothiazoles | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.